Delivery Order SPE2DB20D2014-SPE2DB25FB73Q
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency (DLA) for CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $5,794.03. This non-competitive delivery order is structured as a firm fixed-price contract with an ultimate completion date of August 18, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of CAPLYTA 42 mg capsules in a quantity of 30 units. This firm fixed price delivery order, valued at $29,358.50 with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,351.92 to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed-price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,060.57 for 30-count bottles of CAPLYTA 42 mg capsules, an atypical antipsychotic medication. The contract, awarded on June 4, 2025, with an ultimate completion date of June 5, 2025, was competitively awarded without set-aside restrictions through a Firm Fixed Price delivery order structure. The Defense Logistics Agency, operating under the Department of Defense, is the funding...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) valued at $3,348.66 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of August 4, 2025, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,468.39 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of CAPLYTA 21 mg capsules (30-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 30 capsules of CAPLYTA 10.5 mg, a prescription antipsychotic medication, with a ceiling value of $5,332.03. The contract, awarded on August 29, 2025, with a completion date of September 2, 2025, utilizes firm fixed pricing and was competitively awarded without set-aside restrictions. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10.7K delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Caplyta 42 mg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be completed by May 9, 2025, and the pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- This is a $11,778.81 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The delivery order was issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
- The Defense Logistics Agency awarded a delivery order valued at $10,244.42 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units). The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FB73QDelivery Order
AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) with a contract ceiling value of $7,558.14. The order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has established itself as a critical vendor for federal military medical procurement through competitive awards. This delivery order for CAPLYTA, an atypical antipsychotic medication used in psychiatric treatment, exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support Defense Health Agency and military healthcare systems. The IDC vehicle under which this order was placed enables flexible procurement of a comprehensive range of pharmaceutical products and medical supplies to serve military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 4/24/25 |